Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2010; 16(45): 5732-5738
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5732
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5732
Table 5 Pancreatic antibody and anti-Saccharomyces cerevisiae positivity according to Crohn’s disease activity index n (%)
| Disease activity according to CDAI | PAB | ASCA | Total | ||
| Negative | Positive | Negative | Positive | ||
| Mild (< 150 points) | 49 (84.5) | 9 (15.5) | 27 (46.6) | 31 (53.4) | 58 (100) |
| Moderate (150-450 points) | 5 (100) | 0 (0) | 0 (0) | 5 (100) | 5 (100) |
| Severe (> 450 points) | 1 (100) | 0 (0) | 0 (0) | 1 (100) | 1 (100) |
| Total | 55 | 9 | 27 | 37 | 64 |
- Citation: Demirsoy H, Ozdil K, Ersoy O, Kesici B, Karaca C, Alkim C, Akbayir N, Erdem LK, Onuk MD, Beyzadeoglu HT. Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives. World J Gastroenterol 2010; 16(45): 5732-5738
- URL: https://www.wjgnet.com/1007-9327/full/v16/i45/5732.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i45.5732